Abstract:Background: Myocarditis is a rare complication of idiopathic inflammatory myopathies (IIMs), which is usually underestimated because of limited applications of endomyocardial biopsy and cardiovascular magnetic resonance (CMR) in clinical routines. Methods: From January 2014 to January 2019, 62 patients with initial untreated IIMs were enrolled, including 31 cases with myocarditis (case group) and 31 cases without cardiac involvement (control group). Myocarditis secondary to IIMs was defined based on definitions of IIMs. All medical data were retrieved from electrical medical records of PUMCH. The differences between two groups in symptoms, serum levels of cardiac troponin I (cTnI), creatine kinase-isozyme and N-terminal pro-brain natriuretic peptide (NT-proBNP) were analyzed. The comparisons of arrhythmia, left ventricular ejection fraction (LVEF) and restrictive diastolic dysfunction between two groups were conducted in the analysis of electrocardiogram and electrocardiogram. Besides, CMR data were analyzed to explore the characteristics of CMR in the identification of myocarditis. Meanwhile, 31 patients with myocarditis were divided into two subgroups based on the activity of anti-mitochondrial antibody M2 (AMA-M2), and the differences between two subgroups in the above tests were also analyzed. Results: Compared with control group, patients with myocarditis exhibited shorter disease durations (defined as the period from onset symptoms of IIM to diagnosis of IIM), more symptoms associated with IIMs, more manifestations of heart failure, and higher frequency of positive AMA-M2 antibody (P<0.05). Patients with myocarditis exhibited elevated levels of cTnI, creatine kinase-isozyme and NT-proBNP compared with control group. In case group, the area under the curve indicating myocarditis for CK-MB, cTnI, and NT-proBNP was 0.654, 0.915 and 0.973, with optimal cut-off values of 24.4 µg/L, 0.1 ng/L and 531 pg/L, respectively. Ventricular arrhythmia, atrial arrhythmia, abnormal Q wave and left anterior fascicular block (LAFB) were showed in 76.7%, 53.3%, 74.2% and 51.6% of patients in case group (P<0.01). Patients of case group were featured as decreased LVEF and restrictive diastolic dysfunction compared with control group (P<0.05). Analyzing CMR data of patients of case group, the basal segments (74.2%) and mid-cavity segments (71.0%) were the most frequently involved areas of late gadolinium-enhancement (LGE), while intramural LGE (54.8%) and subendocardial LGE (51.6%) were reported more commonly than subepicardial LGE (19.4%). In patients with myocarditis and positive AMA-M2 antibody, LVEF and right ventricular ejection factor (RVEF) were decreased, and more cases presented diffuse LGE than those with negative AMA-M2 antibody (P<0.05). Conclusions: Symptoms of heart failure and arrhythmias, elevated levels of cTnI and NT-proBNP, and positive AMA-M2 antibody play an important role in the identification of myocarditis in IIMs. Most frequently involved areas of LGE were found in the ventricular septal, basal and mid-cavity segments, as well as in the sub-endocardium and intramural myocardium. Diffuse LGE is common in the detection, which is correlated with AMA-M2 antibody in patients with myocarditis related to IIMs.

Functions and Clinical Significance of Myocardial Cell-Derived Immunoglobulins.

Immunoglobulin kappa light chain produced by cardiomyocytes and participates in maintaining intercalated disc integrity

Immunoglobulin M, a Novel Molecule of Myocardial Cells of Mice.

Quantitative Proteomics Reveals Differential Immunoglobulin-Associated Proteome (igap) in Patients of Acute Myocardial Infarction and Chronic Coronary Syndromes.

The Roles of Cardiac Fibroblasts and Endothelial Cells in Myocarditis

GW25-e3342 Immunoglobulin Expressed in Mice Myocardial Tissue and Localization in Myocardial Fibrosis Tissue

Therapy with Immuoglobulin Ameliorates Giant Cell Myocarditis in Rats

Immunoglobulin Expression in Mice Myocardial Tissue and Its Localization in Myocardial Fibrosis Tissue

Myocardial B cells have specific gene expression and predicted interactions in dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy

Dynamic Profile of CD4+ T-Cell-Associated Cytokines/Chemokines Following Murine Myocardial Infarction/Reperfusion

Role of T Cells in Viral and Immune-mediated Myocarditis

From Cardiac Myosin to the Beta Receptor: Autoantibodies Promote a Fibrotic Transcriptome and Reduced Ventricular Recovery in Human Myocarditis

Matricellular proteins: From cardiac homeostasis to immune regulation

Immunohistological Changes In Dilated Cardiomyopathy Induced By Immunoadsorption Therapy And Subsequent Immunoglobulin Substitution

Influence of Intravenous-Immunoglobulin on T Lymphocyte Subsets, NK Cell and Some Cytokines in Mice with Experimental Viral Myocarditis

Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies

Role of immune cells in the pathogenesis of myocarditis

Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression

Immune cells and related cytokines in dilated cardiomyopathy

Immunopathogenesis of Myocarditis: the Interplay Between Cardiac Fibroblast Cells, Dendritic Cells, Macrophages and CD4+T Cells

An Altered Left Ventricle Protein Profile in Human Ischemic Cardiomyopathy Revealed in Comparative Quantitative Proteomics